The Assessment of Novel Functional Risk Factors for the Prediction of Cardiovascular Events in Vulnerable Patients Following Acute Coronary Syndrome
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Acute Coronary Syndrome
- Sponsor
- Mayo Clinic
- Enrollment
- 101
- Locations
- 1
- Primary Endpoint
- Unstable Angina, Myocardial Infarction, Repeat Revascularization, Cardiac Death, Stroke
- Status
- Completed
- Last Updated
- 10 years ago
Overview
Brief Summary
The purpose of this study is to determine if testing patients for endothelial dysfunction will help identify which patients are more likely at risk to have another heart attack in the future. Study participants will undergo mental stress testing while at the same time being connected to a device that measures endothelial function via the Endopat device. These same participants will also undergo a sleep study via the Watchpat device.
Investigators
Amir Lerman
M.D., Principal Investigator
Mayo Clinic
Eligibility Criteria
Inclusion Criteria
- •Patients undergoing revascularization by percutaneous intervention (PCI) for Acute Coronary Syndrome (ACS) at Mayo (STEMI and NonSTEMI patients)
- •Age greater than 18
Exclusion Criteria
- •Patients likely not to complete the study due to co-morbid conditions (end stage renal disease; liver failure; malignancies)
- •Inability to sign a consent form or availability for follow up
- •Patients unable to tolerate the blood pressure cuff inflation on both arms
- •patients with tremors
- •sustained non-sinus cardiac arrhythmias
- •acrylic finger nails
- •permanent pacemaker
- •color blindness
- •use of alpha blockers and short acting nitrates \< 3 hours before study
- •Federal Medical Center inmates
Outcomes
Primary Outcomes
Unstable Angina, Myocardial Infarction, Repeat Revascularization, Cardiac Death, Stroke
Time Frame: Will determine with statistical analysis after all patients have had 2 year follow-up
Secondary Outcomes
- Quality of Life(6 months post revascularization.)